scanance.
Sign inGet Premium
AI

Albany International Corp.

AINConsumer CyclicalNASDAQ

Textile Manufacturing · Last scanned May 29, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.18B
-3.9% YoY
Net Income
-$57.3M
-165.4% YoY
EBITDA
$51.9M
-76.7% YoY
Free Cash Flow
$33.5M

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About Albany International Corp.

Part of the consumer cyclical sector, Albany International Corp. (AIN) is listed under Textile Manufacturing. The $1.83B market capitalization puts AIN squarely in small-cap range for its industry. The company operates through two segments: Machine Clothing (MC) and Albany Engineered Composites (AEC).

Key stats
Market Cap$1.83B
Fwd P/E21.62
EPS$-1.96
Beta1.18
52W Change-2.1%
Dividend Yield1.73%
ROE-7.2%
Analysis

On the balance sheet, AIN has $122.6M in cash with $476.8M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $33.5M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -7.2%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has been uneven over recent years, ranging from $1.03B to $1.18B.

As with any equity investment, AIN carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing AIN.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms